CN Stock MarketDetailed Quotes
002100 Tecon Biology Co.Ltd
- 6.95
- -0.13-1.84%
Market Closed Dec 13 15:00 CST
9.49BMarket Cap-32.33P/E (TTM)
7.14High6.95Low448.03KlotVolume7.12Open7.08Pre Close315.38MTurnover3.28%Turnover RatioLossP/E (Static)1.37BShares9.0852wk High1.37P/B9.49BFloat Cap5.6752wk Low7.79Limit Up1.37BShs Float19.02Historical High6.37Limit Down2.68%Amplitude-0.32Historical Low--Dividend TTM7.04Avg Price268.54KlotAsk--Div YieldTTM100Lot Size168.89KlotBid
Tecon Biology Co.Ltd Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.01%13.09B | -10.82%7.99B | -2.93%3.78B | 13.74%19.03B | 14.13%14.71B | 11.92%8.96B | 14.71%3.89B | 6.47%16.73B | 4.51%12.89B | 1.16%8.01B |
| Operating revenue | -11.01%13.09B | -10.82%7.99B | -2.93%3.78B | 13.74%19.03B | 14.13%14.71B | 11.92%8.96B | 14.71%3.89B | 6.47%16.73B | 4.51%12.89B | 1.16%8.01B |
| Other operating revenue | ---- | -26.76%13.47M | ---- | 69.81%52.75M | ---- | 22.14%18.4M | ---- | -34.50%31.07M | ---- | 54.03%15.06M |
| Total operating cost | -16.91%12.62B | -16.84%7.79B | -4.84%3.68B | 22.17%20B | 19.67%15.19B | 14.70%9.37B | 10.50%3.87B | 2.63%16.37B | 3.59%12.69B | 9.85%8.17B |
| Operating cost | -18.32%11.52B | -18.43%7.07B | -6.78%3.31B | 23.33%18.47B | 21.24%14.1B | 16.23%8.67B | 12.89%3.55B | 5.41%14.98B | 5.29%11.63B | 12.09%7.46B |
| Operating tax surcharges | -0.68%33.02M | 2.79%21.71M | 2.31%10.09M | 20.85%46.8M | 35.75%33.25M | 25.75%21.12M | 46.26%9.86M | 1.02%38.72M | -11.10%24.49M | -10.39%16.79M |
| Operating expense | -9.53%353.35M | -6.31%233.33M | 20.94%129.38M | 10.12%543.06M | 7.07%390.58M | 6.59%249.05M | 3.97%106.98M | -2.78%493.14M | 8.56%364.81M | 10.46%233.65M |
| Administration expense | 6.91%345.48M | 2.55%223.81M | 16.16%121.77M | 1.87%486.69M | -16.37%323.16M | -17.31%218.25M | -28.63%104.83M | -42.52%477.75M | -34.00%386.44M | -30.26%263.94M |
| Financial expense | -25.44%117.2M | -23.21%81.93M | -22.72%41.54M | -5.44%191.95M | -1.05%157.2M | -4.24%106.69M | -8.70%53.76M | 5.77%202.99M | 6.44%158.87M | 5.97%111.42M |
| -Interest expense (Financial expense) | -30.95%137.88M | -31.41%95.46M | -34.33%46.52M | -1.21%245.54M | 6.23%199.67M | -3.15%139.18M | 8.54%70.84M | 20.61%248.55M | 15.73%187.97M | 36.04%143.7M |
| -Interest Income (Financial expense) | 35.09%-28.57M | 34.39%-19.72M | 46.95%-7.99M | -19.58%-57.48M | -83.83%-44.01M | -103.83%-30.06M | -112.17%-15.06M | -199.15%-48.07M | -122.82%-23.94M | -104.32%-14.75M |
| Research and development | 40.10%249.63M | 56.26%154.29M | 65.51%66.46M | 43.58%257.23M | 45.64%178.18M | 25.51%98.74M | 5.32%40.16M | 4.63%179.16M | 18.55%122.35M | 23.94%78.67M |
| Credit Impairment Loss | 40.98%-29.9M | 57.74%-16.97M | 11.58%-19.01M | -5.64%-53.2M | -25.41%-50.65M | -3.52%-40.16M | 51.59%-21.5M | -104.53%-50.36M | 8.85%-40.39M | 13.16%-38.8M |
| Asset Impairment Loss | 293.90%95.72M | 303.32%96.34M | ---1.06M | -369.52%-500.19M | -190.05%-49.36M | -186.44%-47.38M | ---- | 72.35%-106.53M | 159.42%54.82M | 159.42%54.82M |
| Other net revenue | 315.95%117.54M | 245.47%113.82M | 45.54%-8.01M | -359.02%-476.67M | -204.59%-54.43M | -290.02%-78.24M | -180.96%-14.71M | 72.72%-103.84M | 144.83%52.04M | 132.29%41.18M |
| Fair value change income | 694.69%72.37K | 139.94%48.77K | -102.94%-448.68 | -100.38%-3.53K | 80.24%-12.17K | -127.48%-122.11K | 102.96%15.27K | --939.45K | -107.70%-61.6K | 96.94%-53.68K |
| Invest income | -106.01%-213.77K | -175.15%-1.15M | -3.60%1.1M | -79.49%3.46M | -72.28%3.56M | -73.45%1.53M | -85.83%1.14M | -45.44%16.87M | -58.53%12.83M | -75.40%5.76M |
| -Including: Investment income associates | -257.36%-2.55M | -276.11%-2.28M | -3.60%1.1M | -102.03%-271.23K | -87.34%1.62M | -77.56%1.29M | -72.35%1.14M | -37.23%13.33M | -14.83%12.79M | -36.21%5.76M |
| Asset deal income | -62.17%2.27M | 116.47%878.02K | --0 | 113.45%3.9M | 1,792.81%5.99M | -743.23%-5.33M | -2,696.07%-2.71M | 21.06%-28.98M | 98.90%-353.84K | 103.28%829.01K |
| Other revenue | 37.56%49.6M | 162.11%34.68M | 31.37%10.96M | 8.03%69.38M | 43.06%36.05M | -28.96%13.23M | 15.35%8.35M | 83.84%64.22M | 20.15%25.2M | 42.78%18.62M |
| Operating profit | 210.10%587.4M | 165.82%317.34M | 736.05%90.55M | -663.02%-1.45B | -314.59%-533.52M | -312.80%-482.15M | 112.34%10.83M | 141.63%256.84M | 776.94%248.62M | -132.94%-116.8M |
| Add:Non operating Income | 1,034.61%18.7M | 39.33%694.08K | 22.59%322.06K | 58.00%2.76M | 65.99%1.65M | -29.33%498.16K | 75.01%262.71K | -55.64%1.75M | -61.19%992.97K | -40.91%704.88K |
| Less:Non operating expense | -3.42%34.11M | 43.64%24.24M | 81.65%12.97M | 16.78%49.69M | 11.57%35.32M | -26.34%16.88M | -29.91%7.14M | -15.75%42.55M | 34.21%31.66M | 53.26%22.91M |
| Total profit | 200.85%571.99M | 158.93%293.8M | 1,871.45%77.9M | -791.09%-1.49B | -360.23%-567.19M | -258.64%-498.52M | 104.04%3.95M | 132.56%216.03M | 477.36%217.95M | -140.78%-139M |
| Less:Income tax cost | -19.06%17.49M | -35.76%14.03M | -16.00%17.72M | -10.00%23.46M | -16.28%21.61M | -5.39%21.84M | 95.90%21.1M | -18.28%26.07M | -40.58%25.81M | -35.62%23.09M |
| Net profit | 194.17%554.5M | 153.76%279.77M | 450.90%60.18M | -898.26%-1.52B | -406.44%-588.8M | -221.03%-520.36M | 84.20%-17.15M | 127.32%189.97M | 289.87%192.14M | -153.14%-162.09M |
| Net profit from continuing operation | 194.17%554.5M | 153.76%279.77M | 450.90%60.18M | -898.26%-1.52B | -406.44%-588.8M | -221.03%-520.36M | 84.20%-17.15M | 127.32%189.97M | 289.87%192.14M | -153.14%-162.09M |
| Less:Minority Profit | 86.82%-11.13M | 104.22%3.08M | 313.22%6.11M | -68.45%-153.11M | -28.26%-84.42M | -13.10%-73.08M | 92.64%-2.87M | -1,320.59%-90.89M | -171.81%-65.82M | -201.55%-64.61M |
| Net profit of parent company owners | 212.14%565.62M | 161.86%276.68M | 478.54%54.06M | -585.61%-1.36B | -295.53%-504.38M | -358.85%-447.29M | 79.48%-14.28M | 139.95%280.74M | 233.76%257.96M | -140.38%-97.48M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --114.92K | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | 210.81%0.41 | 160.61%0.2 | 500.00%0.04 | -580.95%-1.01 | -294.74%-0.37 | -371.43%-0.33 | 80.00%-0.01 | 132.81%0.21 | 205.56%0.19 | -131.82%-0.07 |
| Diluted earning per share | 210.81%0.41 | 160.61%0.2 | 500.00%0.04 | -580.95%-1.01 | -294.74%-0.37 | -371.43%-0.33 | 80.00%-0.01 | 133.33%0.21 | 205.56%0.19 | -131.82%-0.07 |
| Other composite income | 9.68%3.09M | -281.02%-40.71M | -634.21%-52.61M | 360.39%49.69M | 122.03%2.81M | 180.29%22.49M | 112.38%9.85M | 217.70%10.79M | -136.99%-12.77M | -275.37%-28.01M |
| Other composite income of parent company owners | 25.26%3.88M | -293.52%-40.83M | -634.21%-52.61M | 369.13%49.69M | 124.24%3.1M | 175.32%21.1M | 112.38%9.85M | 215.50%10.59M | -136.99%-12.77M | -275.37%-28.01M |
| Other composite income of minority owners | -181.06%-791.02K | -91.28%121.2K | ---- | ---- | ---281.44K | --1.39M | ---- | --201.16K | ---- | ---- |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---114.92K | ---- | ---- |
| Total composite income | 195.15%557.58M | 148.01%239.05M | 203.63%7.57M | -831.01%-1.47B | -426.70%-585.99M | -161.90%-497.87M | 96.12%-7.3M | 128.48%200.65M | 369.06%179.37M | -159.22%-190.1M |
| Total composite income of parent company owners | 213.61%569.5M | 155.34%235.85M | 132.78%1.45M | -550.89%-1.31B | -304.45%-501.29M | -239.61%-426.19M | 97.03%-4.43M | 140.92%291.34M | 254.86%245.19M | -148.76%-125.49M |
| Total composite income of minority owners | 85.93%-11.92M | 104.47%3.2M | 313.22%6.11M | -68.83%-153.11M | -28.69%-84.7M | -10.95%-71.69M | 92.64%-2.87M | -1,317.89%-90.69M | -171.81%-65.82M | -201.55%-64.61M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
